Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis.

van Wijhe M, de Boer PT, de Jong HJ, van Vliet H, Wallinga J, Postma MJ.

Vaccine. 2019 Sep 10;37(38):5698-5707. doi: 10.1016/j.vaccine.2019.07.097. Epub 2019 Aug 13.

2.

Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis.

Uzorka JW, Wallinga J, Kroft LJM, Ottenhoff THM, Arend SM.

Open Forum Infect Dis. 2019 Jul 1;6(7). pii: ofz313. doi: 10.1093/ofid/ofz313.

3.

A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact Infections.

Hoang T, Coletti P, Melegaro A, Wallinga J, Grijalva CG, Edmunds JW, Beutels P, Hens N.

Epidemiology. 2019 Sep;30(5):723-736. doi: 10.1097/EDE.0000000000001047.

4.

Nowcasting the Number of New Symptomatic Cases During Infectious Disease Outbreaks Using Constrained P-spline Smoothing.

van de Kassteele J, Eilers PHC, Wallinga J.

Epidemiology. 2019 Sep;30(5):737-745. doi: 10.1097/EDE.0000000000001050.

5.

Landscape dynamics revealed by luminescence signals of feldspars from fluvial terraces.

Bonnet S, Reimann T, Wallinga J, Lague D, Davy P, Lacoste A.

Sci Rep. 2019 Jun 12;9(1):8569. doi: 10.1038/s41598-019-44533-4.

6.

Capturing multiple-type interactions into practical predictors of type replacement following human papillomavirus vaccination.

Man I, Auranen K, Wallinga J, Bogaards JA.

Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180298. doi: 10.1098/rstb.2018.0298.

PMID:
30955490
7.

Visual tools to assess the plausibility of algorithm-identified infectious disease clusters: an application to mumps data from the Netherlands dating from January 2009 to June 2016.

Soetens L, Backer JA, Hahné S, van Binnendijk R, Gouma S, Wallinga J.

Euro Surveill. 2019 Mar;24(12). doi: 10.2807/1560-7917.ES.2019.24.12.1800331.

8.

Cost-effectiveness of increased HIV testing among MSM in The Netherlands.

Reitsema M, Steffers L, Visser M, Heijne J, van Hoek AJ, Schim van der Loeff M, van Sighem A, van Benthem B, Wallinga J, Xiridou M, Mangen MJ.

AIDS. 2019 Oct 1;33(12):1807-1817. doi: 10.1097/QAD.0000000000002199.

PMID:
30889012
9.

Optical bleaching front in bedrock revealed by spatially-resolved infrared photoluminescence.

Sellwood EL, Guralnik B, Kook M, Prasad AK, Sohbati R, Hippe K, Wallinga J, Jain M.

Sci Rep. 2019 Feb 22;9(1):2611. doi: 10.1038/s41598-019-38815-0.

10.

Spatial early warning signals for impending regime shifts: A practical framework for application in real-world landscapes.

Nijp JJ, Temme AJAM, van Voorn GAK, Kooistra L, Hengeveld GM, Soons MB, Teuling AJ, Wallinga J.

Glob Chang Biol. 2019 Jun;25(6):1905-1921. doi: 10.1111/gcb.14591. Epub 2019 Apr 1. Review.

PMID:
30761695
11.

Vaccinating children against influenza increases variability in epidemic size.

Backer JA, van Boven M, van der Hoek W, Wallinga J.

Epidemics. 2019 Mar;26:95-103. doi: 10.1016/j.epidem.2018.10.003. Epub 2018 Oct 10.

12.

Echovirus type 6 transmission clusters and the role of environmental surveillance in early warning, the Netherlands, 2007 to 2016.

Monge S, Benschop K, Soetens L, Pijnacker R, Hahné S, Wallinga J, Duizer E.

Euro Surveill. 2018 Nov;23(45). doi: 10.2807/1560-7917.ES.2018.23.45.1800288.

13.

Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies.

van de Peppel RJ, van der Beek MT, Visser LG, de Boer MGJ, Wallinga J.

Int J Antimicrob Agents. 2019 Mar;53(3):284-293. doi: 10.1016/j.ijantimicag.2018.10.021. Epub 2018 Nov 2.

PMID:
30395989
14.

Controls on late-Holocene drift-sand dynamics: The dominant role of human pressure in the Netherlands.

Pierik HJ, van Lanen RJ, Gouw-Bouman MT, Groenewoudt BJ, Wallinga J, Hoek WZ.

Holocene. 2018 Sep;28(9):1361-1381. doi: 10.1177/0959683618777052. Epub 2018 Jun 25.

15.

Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events.

Wijn DH, Groeneveld GH, Vollaard AM, Muller M, Wallinga J, Gelderblom H, Smit EF.

Eur J Cancer. 2018 Nov;104:182-187. doi: 10.1016/j.ejca.2018.09.012. Epub 2018 Oct 24.

PMID:
30368069
16.

The impact of influenza vaccination on infection, hospitalisation and mortality in the Netherlands between 2003 and 2015.

Backer JA, Wallinga J, Meijer A, Donker GA, van der Hoek W, van Boven M.

Epidemics. 2019 Mar;26:77-85. doi: 10.1016/j.epidem.2018.10.001. Epub 2018 Oct 11.

17.

[Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands].

Tulen AD, van Wijhe M, Korthals Altes H, McDonald SA, de Melker HE, Postma MJ, Wallinga J.

Ned Tijdschr Geneeskd. 2018 Sep 20;162. pii: D2983. Dutch.

PMID:
30306758
18.

The tip of the iceberg: incompleteness of measles reporting during a large outbreak in The Netherlands in 2013-2014.

Woudenberg T, Woonink F, Kerkhof J, Cox K, Ruijs WLM, van Binnendijk R, de Melker H, Hahné SJM, Wallinga J.

Epidemiol Infect. 2018 Oct 9:1-7. doi: 10.1017/S0950268818002698. [Epub ahead of print]

PMID:
30298798
19.

Metropolitan versus small-town influenza.

Wallinga J.

Science. 2018 Oct 5;362(6410):29-30. doi: 10.1126/science.aav1003. No abstract available.

PMID:
30287649
20.

S. typhi Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease.

von Asmuth EGJ, Brockhoff HJ, Wallinga J, Visser LG.

J Travel Med. 2019 Jan 1;26(1). doi: 10.1093/jtm/tay073.

PMID:
30137469
21.

Mycoplasma amphoriforme vs M. pneumoniae: similarities and differences between patient characteristics in a regional hospital in the Netherlands.

van Schaik ML, Patberg KW, Wallinga JG, Wolfhagen MJHM, Bruijnesteijn van Coppenraet LES.

J Med Microbiol. 2018 Sep;67(9):1348-1350. doi: 10.1099/jmm.0.000809. Epub 2018 Jul 27.

PMID:
30051803
22.

Inferring Pathogen Type Interactions Using Cross-sectional Prevalence Data: Opportunities and Pitfalls for Predicting Type Replacement.

Man I, Wallinga J, Bogaards JA.

Epidemiology. 2018 Sep;29(5):666-674. doi: 10.1097/EDE.0000000000000870.

PMID:
29923864
23.

Anatomy of Mississippi Delta growth and its implications for coastal restoration.

Chamberlain EL, Törnqvist TE, Shen Z, Mauz B, Wallinga J.

Sci Adv. 2018 Apr 11;4(4):eaar4740. doi: 10.1126/sciadv.aar4740. eCollection 2018 Apr.

24.

The Reduction of Measles Transmission During School Vacations.

Klinkenberg D, Hahné SJM, Woudenberg T, Wallinga J.

Epidemiology. 2018 Jul;29(4):562-570. doi: 10.1097/EDE.0000000000000841.

PMID:
29629940
25.

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination.

Winter AK, Martinez ME, Cutts FT, Moss WJ, Ferrari MJ, McKee A, Lessler J, Hayford K, Wallinga J, Metcalf CJE.

J Infect Dis. 2018 Jul 2;218(3):355-364. doi: 10.1093/infdis/jiy137. Erratum in: J Infect Dis. 2018 Aug 14;218(6):1014.

26.

Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands.

van Wijhe M, Tulen AD, Korthals Altes H, McDonald SA, de Melker HE, Postma MJ, Wallinga J.

Epidemiol Infect. 2018 Apr;146(6):716-722. doi: 10.1017/S0950268818000481. Epub 2018 Mar 14.

PMID:
29534768
27.

Years of Life Lost Due to Influenza-Attributable Mortality in Older Adults in the Netherlands: A Competing-Risks Approach.

McDonald SA, van Wijhe M, van Asten L, van der Hoek W, Wallinga J.

Am J Epidemiol. 2018 Aug 1;187(8):1791-1798. doi: 10.1093/aje/kwy021.

PMID:
29420681
28.

Estimating the Population-Level Effectiveness of Vaccination Programs in the Netherlands.

van Wijhe M, McDonald SA, de Melker HE, Postma MJ, Wallinga J.

Epidemiology. 2018 Mar;29(2):215-223. doi: 10.1097/EDE.0000000000000778.

PMID:
29087989
29.

Real-time Estimation of Epidemiologic Parameters from Contact Tracing Data During an Emerging Infectious Disease Outbreak.

Soetens L, Klinkenberg D, Swaan C, Hahné S, Wallinga J.

Epidemiology. 2018 Mar;29(2):230-236. doi: 10.1097/EDE.0000000000000776.

PMID:
29087987
30.

Variation in loss of immunity shapes influenza epidemics and the impact of vaccination.

Woolthuis RG, Wallinga J, van Boven M.

BMC Infect Dis. 2017 Sep 19;17(1):632. doi: 10.1186/s12879-017-2716-y.

31.

Dot map cartograms for detection of infectious disease outbreaks: an application to Q fever, the Netherlands and pertussis, Germany.

Soetens L, Hahné S, Wallinga J.

Euro Surveill. 2017 Jun 29;22(26). pii: 30562. doi: 10.2807/1560-7917.ES.2017.22.26.30562.

32.

Simultaneous inference of phylogenetic and transmission trees in infectious disease outbreaks.

Klinkenberg D, Backer JA, Didelot X, Colijn C, Wallinga J.

PLoS Comput Biol. 2017 May 18;13(5):e1005495. doi: 10.1371/journal.pcbi.1005495. eCollection 2017 May.

33.

Determinants of Rotavirus Transmission: A Lag Nonlinear Time Series Analysis.

van Gaalen RD, van de Kassteele J, Hahné SJM, Bruijning-Verhagen P, Wallinga J.

Epidemiology. 2017 Jul;28(4):503-513. doi: 10.1097/EDE.0000000000000654.

34.

Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a bivalent A/H3N2 vaccine component.

Worby CJ, Wallinga J, Lipsitch M, Goldstein E.

Epidemics. 2017 Jun;19:74-82. doi: 10.1016/j.epidem.2017.02.008. Epub 2017 Feb 21.

35.

An Evidence Synthesis Approach to Estimating the Proportion of Influenza Among Influenza-like Illness Patients.

McDonald SA, van Boven M, Wallinga J.

Epidemiology. 2017 Jul;28(4):484-491. doi: 10.1097/EDE.0000000000000646.

PMID:
28252453
36.

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology.

Woudenberg T, van Binnendijk RS, Sanders EA, Wallinga J, de Melker HE, Ruijs WL, Hahné SJ.

Euro Surveill. 2017 Jan 19;22(3). pii: 30443. doi: 10.2807/1560-7917.ES.2017.22.3.30443.

37.

Mumps transmission in social networks: a cohort study.

Hahné S, Schurink T, Wallinga J, Kerkhof J, van der Sande M, van Binnendijk R, de Melker H.

BMC Infect Dis. 2017 Jan 10;17(1):56. doi: 10.1186/s12879-016-2135-5.

38.

The impact of individual-level heterogeneity on estimated infectious disease burden: a simulation study.

McDonald SA, Devleesschauwer B, Wallinga J.

Popul Health Metr. 2016 Dec 8;14:47.

39.

Spatiotemporal Analysis of the 2014 Ebola Epidemic in West Africa.

Backer JA, Wallinga J.

PLoS Comput Biol. 2016 Dec 8;12(12):e1005210. doi: 10.1371/journal.pcbi.1005210. eCollection 2016 Dec.

40.

The most efficient critical vaccination coverage and its equivalence with maximizing the herd effect.

Duijzer E, van Jaarsveld W, Wallinga J, Dekker R.

Math Biosci. 2016 Dec;282:68-81. doi: 10.1016/j.mbs.2016.09.017. Epub 2016 Oct 8.

PMID:
27729237
41.

Inferring R0 in emerging epidemics-the effect of common population structure is small.

Trapman P, Ball F, Dhersin JS, Tran VC, Wallinga J, Britton T.

J R Soc Interface. 2016 Aug;13(121). pii: 20160288. doi: 10.1098/rsif.2016.0288.

42.

Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.

Xiridou M, Lugnér A, de Vries HJ, van Bergen JE, Götz HM, van Benthem BH, Wallinga J, van der Sande MA.

Sex Transm Dis. 2016 Sep;43(9):542-8. doi: 10.1097/OLQ.0000000000000480.

PMID:
27513379
43.

Monitoring the spread of meticillin-resistant Staphylococcus aureus in The Netherlands from a reference laboratory perspective.

Donker T, Bosch T, Ypma RJ, Haenen AP, van Ballegooijen WM, Heck ME, Schouls LM, Wallinga J, Grundmann H.

J Hosp Infect. 2016 Aug;93(4):366-74. doi: 10.1016/j.jhin.2016.02.022. Epub 2016 Mar 15.

44.

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.

van Lier A, McDonald SA, Bouwknegt M; EPI group, Kretzschmar ME, Havelaar AH, Mangen MJ, Wallinga J, de Melker HE.

PLoS One. 2016 Apr 20;11(4):e0153106. doi: 10.1371/journal.pone.0153106. eCollection 2016.

45.

The Role of Nursing Homes in the Spread of Antimicrobial Resistance Over the Healthcare Network.

van den Dool C, Haenen A, Leenstra T, Wallinga J.

Infect Control Hosp Epidemiol. 2016 Jul;37(7):761-7. doi: 10.1017/ice.2016.59. Epub 2016 Apr 7.

46.

End TB strategy: the need to reduce risk inequalities.

Gomes MG, Barreto ML, Glaziou P, Medley GF, Rodrigues LC, Wallinga J, Squire SB.

BMC Infect Dis. 2016 Mar 22;16:132. doi: 10.1186/s12879-016-1464-8.

47.

Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis.

van Wijhe M, McDonald SA, de Melker HE, Postma MJ, Wallinga J.

Lancet Infect Dis. 2016 May;16(5):592-598. doi: 10.1016/S1473-3099(16)00027-X. Epub 2016 Feb 10.

PMID:
26873665
48.

The impact of national vaccination policy changes on influenza incidence in the Netherlands.

McDonald SA, van Asten L, van der Hoek W, Donker GA, Wallinga J.

Influenza Other Respir Viruses. 2016 Mar;10(2):76-85. doi: 10.1111/irv.12366. Epub 2016 Feb 2.

49.

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.

van Lier A, Lugnér A, Opstelten W, Jochemsen P, Wallinga J, Schellevis F, Sanders E, de Melker H, van Boven M.

EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct.

50.

On the relative role of different age groups in influenza epidemics.

Worby CJ, Chaves SS, Wallinga J, Lipsitch M, Finelli L, Goldstein E.

Epidemics. 2015 Dec;13:10-16.

Supplemental Content

Loading ...
Support Center